Jeffrey D Chulay

Summary

Publications

  1. ncbi Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
    Jeffrey D Chulay
    Applied Genetic Technologies Corporation, 11801 Research Drive, Alachua, FL 32615, USA
    Hum Gene Ther 22:155-65. 2011

Research Grants

  1. Phase 1/2 Trial of rAAV2-CB-hRPE65 (BB-IND 13848, 11 Sep 2009) for Leber Congenit
    Jeffrey D Chulay; Fiscal Year: 2010
  2. Phase 2 Study of rAAV1-CB-hAAT for Treatment of Alpha-1 Antitrypsin Deficiency
    Jeffrey D Chulay; Fiscal Year: 2010

Detail Information

Publications1

  1. ncbi Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
    Jeffrey D Chulay
    Applied Genetic Technologies Corporation, 11801 Research Drive, Alachua, FL 32615, USA
    Hum Gene Ther 22:155-65. 2011
    ..These results support continued development of rAAV-CB-hAAT for treatment of AAT deficiency...

Research Grants2

  1. Phase 1/2 Trial of rAAV2-CB-hRPE65 (BB-IND 13848, 11 Sep 2009) for Leber Congenit
    Jeffrey D Chulay; Fiscal Year: 2010
    ..Efficacy will be measured by evaluation of visual fields, visual acuity and electroretinography. ..
  2. Phase 2 Study of rAAV1-CB-hAAT for Treatment of Alpha-1 Antitrypsin Deficiency
    Jeffrey D Chulay; Fiscal Year: 2010
    ..Results from this Phase 2 trial will be used to develop a Phase 3 study designed to satisfy the requirements for licensure of a gene therapy treatment for this orphan disease. ..